PEGVISOMANT for Pituitary tumour benign: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 48 adverse event reports in the FDA FAERS database where PEGVISOMANT was used for Pituitary tumour benign.

Most Reported Side Effects for PEGVISOMANT

Side Effect	Reports	%	Deaths	Hosp.
Off label use	460	15.3%	27	64
Drug ineffective	328	10.9%	2	32
Insulin-like growth factor increased	320	10.6%	2	43
Product dose omission issue	255	8.5%	2	36
Headache	244	8.1%	1	41
Fatigue	224	7.4%	6	38
Arthralgia	184	6.1%	1	31
Death	162	5.4%	162	11
Injection site pain	161	5.3%	1	23
Product use issue	158	5.2%	11	52
Diarrhoea	151	5.0%	1	39
Nausea	142	4.7%	0	45
Pain	121	4.0%	0	22
Malaise	114	3.8%	3	23
Needle issue	110	3.7%	0	18